Genetic Architecture of Pediatric Cardiomyopathies Assessed by Whole-Exome Sequencing: Insights Into Early-Onset and

Luana Giovannangeli1, Elise Daire2,3, Kahia Messaoudi1,3

  • 1Laboratoire de Génétique Constitutionnelle, CHU Amiens-Picardie, Amiens, France.

Clinical Genetics
|August 14, 2026
PubMed

Insights

Whole-exome sequencing (WES) is effective for diagnosing pediatric cardiomyopathies (CM), identifying genetic variants in over 60% of cases. Early diagnosis and syndromic genes are crucial for understanding severe pediatric heart conditions.

Area of Science:

  • Pediatric Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Pediatric cardiomyopathies (CM) are rare, heterogeneous heart muscle disorders in children.
  • Genetic basis of adult CM is known, but less defined in pediatric forms, especially early-onset and syndromic cases.

Purpose of the Study:

  • To characterize the genetic architecture of pediatric cardiomyopathies (CM).
  • To evaluate the utility of Whole-Exome Sequencing (WES) in diagnosing pediatric CM.

Main Methods:

  • Retrospective study of 59 pediatric patients with CM from 2018-2024.
  • Whole-Exome Sequencing (WES) was performed to identify genetic variants.

Main Results:

  • WES identified at least one Variant Of Interest (VOI) in 62.7% of patients.
  • Pathogenic/Likely Pathogenic (P/LP) variants were found in 45.8% of cases; 16.9% were Variants of Uncertain Significance (VUS).
  • Higher diagnostic yield for hypertrophic CM (HCM) (67.7%) and dilated CM (DCM) (57.1%), particularly in infants diagnosed before 1 year (72.7%).
  • Significant proportion (55%) of patients diagnosed before 6 months had variants in syndromic genes, even with initially isolated cardiac phenotypes.

Conclusions:

  • WES is a valuable first-line diagnostic tool for pediatric CM.
  • Complex and syndromic genetic factors significantly contribute to early-onset and severe pediatric cardiomyopathies.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...